These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 14580238)
1. Characterization of a pseudoachondroplasia-associated mutation (His587-->Arg) in the C-terminal, collagen-binding domain of cartilage oligomeric matrix protein (COMP). Spitznagel L; Nitsche DP; Paulsson M; Maurer P; Zaucke F Biochem J; 2004 Jan; 377(Pt 2):479-87. PubMed ID: 14580238 [TBL] [Abstract][Full Text] [Related]
2. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding. Hou J; Putkey JA; Hecht JT Cell Calcium; 2000 Jun; 27(6):309-14. PubMed ID: 11013461 [TBL] [Abstract][Full Text] [Related]
3. COMP mutations, chondrocyte function and cartilage matrix. Hecht JT; Hayes E; Haynes R; Cole WG Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129 [TBL] [Abstract][Full Text] [Related]
4. Role of TSP-5/COMP in pseudoachondroplasia. Posey KL; Hayes E; Haynes R; Hecht JT Int J Biochem Cell Biol; 2004 Jun; 36(6):1005-12. PubMed ID: 15094116 [TBL] [Abstract][Full Text] [Related]
5. MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures. Roman-Blas J; Dion AS; Seghatoleslami MR; Giunta K; Oca P; Jimenez SA; Williams CJ J Cell Physiol; 2010 Sep; 224(3):817-26. PubMed ID: 20578249 [TBL] [Abstract][Full Text] [Related]
6. Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. Thur J; Rosenberg K; Nitsche DP; Pihlajamaa T; Ala-Kokko L; Heinegård D; Paulsson M; Maurer P J Biol Chem; 2001 Mar; 276(9):6083-92. PubMed ID: 11084047 [TBL] [Abstract][Full Text] [Related]
7. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes. Chen TL; Posey KL; Hecht JT; Vertel BM J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134 [TBL] [Abstract][Full Text] [Related]
8. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH. Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310 [TBL] [Abstract][Full Text] [Related]
9. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate. Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431 [TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519 [TBL] [Abstract][Full Text] [Related]
11. Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of cartilage collagen fibril growth in mouse chondrocyte cultures. Blumbach K; Bastiaansen-Jenniskens YM; DeGroot J; Paulsson M; van Osch GJ; Zaucke F Arthritis Rheum; 2009 Dec; 60(12):3676-85. PubMed ID: 19950300 [TBL] [Abstract][Full Text] [Related]
12. Identification of novel and recurrent mutations in the calcium binding type III repeats of cartilage oligomeric matrix protein in patients with pseudoachondroplasia. Cao LH; Wang LB; Wang SS; Ma HW; Ji CY; Luo Y Genet Mol Res; 2011 May; 10(2):955-63. PubMed ID: 21644213 [TBL] [Abstract][Full Text] [Related]
13. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype. Merritt TM; Alcorn JL; Haynes R; Hecht JT J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635 [TBL] [Abstract][Full Text] [Related]
14. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP. Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347 [TBL] [Abstract][Full Text] [Related]
15. Disease-causing mutations in cartilage oligomeric matrix protein cause an unstructured Ca2+ binding domain. Kleerekoper Q; Hecht JT; Putkey JA J Biol Chem; 2002 Mar; 277(12):10581-9. PubMed ID: 11782471 [TBL] [Abstract][Full Text] [Related]
16. A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasia-causing mutation (p.H587R) disrupts collagen fibrillogenesis. Hansen U; Platz N; Becker A; Bruckner P; Paulsson M; Zaucke F Arthritis Rheum; 2011 Jan; 63(1):159-67. PubMed ID: 20936634 [TBL] [Abstract][Full Text] [Related]
17. Novel mutations of the cartilage oligomeric matrix protein (COMP) gene in two Japanese patients with pseudoachondroplasia. Nakayama H; Endo Y; Aota S; Sato M; Fujita T; Kikuchi S Oncol Rep; 2003; 10(4):871-3. PubMed ID: 12792737 [TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids. Vilim V; Lenz ME; Vytasek R; Masuda K; Pavelka K; Kuettner KE; Thonar EJ Arch Biochem Biophys; 1997 May; 341(1):8-16. PubMed ID: 9143347 [TBL] [Abstract][Full Text] [Related]
19. Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways. Dinser R; Zaucke F; Kreppel F; Hultenby K; Kochanek S; Paulsson M; Maurer P J Clin Invest; 2002 Aug; 110(4):505-13. PubMed ID: 12189245 [TBL] [Abstract][Full Text] [Related]
20. Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Budde B; Blumbach K; Ylöstalo J; Zaucke F; Ehlen HW; Wagener R; Ala-Kokko L; Paulsson M; Bruckner P; Grässel S Mol Cell Biol; 2005 Dec; 25(23):10465-78. PubMed ID: 16287859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]